Nathan A. Lack

4.2k total citations
55 papers, 1.4k citations indexed

About

Nathan A. Lack is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Nathan A. Lack has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 12 papers in Genetics. Recurrent topics in Nathan A. Lack's work include Prostate Cancer Treatment and Research (18 papers), Estrogen and related hormone effects (10 papers) and Tuberculosis Research and Epidemiology (8 papers). Nathan A. Lack is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Estrogen and related hormone effects (10 papers) and Tuberculosis Research and Epidemiology (8 papers). Nathan A. Lack collaborates with scholars based in Türkiye, Canada and United Kingdom. Nathan A. Lack's co-authors include Edith Sim, Artem Cherkasov, Paul S. Rennie, Eric Leblanc, Peter Axerio-Cilies, Isaac M. Westwood, Emma Tomlinson Guns, Elizabeth Fullam, Akane Kawamura and E.D. Lowe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Nathan A. Lack

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan A. Lack Türkiye 22 668 306 246 218 169 55 1.4k
Taoufik Ouatas United States 23 866 1.3× 463 1.5× 145 0.6× 183 0.8× 337 2.0× 38 1.8k
Joan Cao United States 13 512 0.8× 88 0.3× 312 1.3× 71 0.3× 260 1.5× 21 1.3k
Alexandre Evrard France 25 841 1.3× 173 0.6× 143 0.6× 71 0.3× 711 4.2× 80 1.9k
Renae M. Crosby United States 17 1.1k 1.6× 248 0.8× 111 0.5× 87 0.4× 459 2.7× 27 1.7k
Victoria J. Findlay United States 26 1.6k 2.4× 194 0.6× 121 0.5× 135 0.6× 362 2.1× 50 2.2k
Amit Kulkarni United States 12 1.2k 1.9× 131 0.4× 217 0.9× 89 0.4× 307 1.8× 19 1.7k
Sih‐Han Liao Taiwan 21 498 0.7× 265 0.9× 268 1.1× 55 0.3× 123 0.7× 46 1.2k
Makoto Asada Japan 21 1.3k 1.9× 312 1.0× 109 0.4× 327 1.5× 563 3.3× 49 2.8k
Naoyuki Kanzaki Japan 27 1.2k 1.7× 339 1.1× 173 0.7× 634 2.9× 646 3.8× 47 2.9k
Daniel A. Harki United States 28 1.6k 2.4× 112 0.4× 185 0.8× 184 0.8× 280 1.7× 77 2.6k

Countries citing papers authored by Nathan A. Lack

Since Specialization
Citations

This map shows the geographic impact of Nathan A. Lack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan A. Lack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan A. Lack more than expected).

Fields of papers citing papers by Nathan A. Lack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan A. Lack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan A. Lack. The network helps show where Nathan A. Lack may publish in the future.

Co-authorship network of co-authors of Nathan A. Lack

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan A. Lack. A scholar is included among the top collaborators of Nathan A. Lack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan A. Lack. Nathan A. Lack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seo, Ji-Heui, Claudia Giambartolomei, Geoffrey M. Nelson, et al.. (2024). Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription. Nature Communications. 15(1). 9494–9494. 4 indexed citations
2.
Wood, Christi L., Lilian L. Nohara, Lonna Munro, et al.. (2023). Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours. Frontiers in Immunology. 13. 982082–982082. 9 indexed citations
3.
Lack, Nathan A., et al.. (2023). 5‐Fluoro/(trifluoromethoxy)‐2‐indolinone derivatives with anti‐interleukin‐1 activity. Archiv der Pharmazie. 356(12). e2300217–e2300217. 3 indexed citations
4.
Nohara, Lilian L., Lonna Munro, Cheryl G. Pfeifer, et al.. (2023). Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours. Frontiers in Pharmacology. 14. 1119620–1119620. 2 indexed citations
5.
Morova, Tunç, Yi Ding, Chia-Chi Flora Huang, et al.. (2022). Optimized high-throughput screening of non-coding variants identified from genome-wide association studies. Nucleic Acids Research. 51(3). e18–e18. 8 indexed citations
6.
Mendes, Adrianna A., Jiayun Lu, Harsimar Kaur, et al.. (2022). Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer. Cancer. 128(12). 2269–2280. 18 indexed citations
7.
Morova, Tunç, Bart Geverts, Tsion E. Abraham, et al.. (2021). DNA binding alters ARv7 dimer interactions. Journal of Cell Science. 134(14). 9 indexed citations
8.
Acar, Ömer, Mert Kılıç, Metin Vural, et al.. (2021). Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations. The Prostate. 82(1). 145–153. 2 indexed citations
9.
Fernández, Michael, et al.. (2019). DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules. Bioinformatics. 36(3). 813–818. 19 indexed citations
10.
Dalal, Kush, Hélène Morin, Fuqiang Ban, et al.. (2018). Small molecule-induced degradation of the full length and V7 truncated variant forms of human androgen receptor. European Journal of Medicinal Chemistry. 157. 1164–1173. 14 indexed citations
11.
Cingöz, Ahmet, Ezgi Kaya-Aksoy, Selena Kazancioglu, et al.. (2016). Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme. Cancer Biology & Therapy. 17(5). 546–557. 31 indexed citations
12.
Acar, Ömer, Ezgi Özkurt, Can Alkan, et al.. (2015). Determining the origin of synchronous multifocal bladder cancer by exome sequencing. BMC Cancer. 15(1). 871–871. 19 indexed citations
13.
Li, Huifang, Mohamed D.H. Hassona, Nathan A. Lack, et al.. (2013). Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer. Molecular Cancer Therapeutics. 12(11). 2425–2435. 24 indexed citations
14.
Acar, Ömer, Tarık Esen, & Nathan A. Lack. (2013). New Therapeutics to Treat Castrate‐Resistant Prostate Cancer. The Scientific World JOURNAL. 2013(1). 379641–379641. 21 indexed citations
15.
Basha, Genc, Kyla Omilusik, Anna T. Reinicke, et al.. (2012). A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nature Immunology. 13(3). 237–245. 103 indexed citations
16.
Singh, Nisha, et al.. (2012). Cloning, expression, purification, crystallization and X-ray analysis of inositol monophosphatase fromMus musculusandHomo sapiens. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 68(10). 1149–1152. 14 indexed citations
17.
18.
Lack, Nathan A., Katherine C. Yam, E.D. Lowe, et al.. (2009). Characterization of a Carbon-Carbon Hydrolase from Mycobacterium tuberculosis Involved in Cholesterol Metabolism. Journal of Biological Chemistry. 285(1). 434–443. 81 indexed citations
19.
Sim, Edith, Nathan A. Lack, Hilary Long, et al.. (2008). Arylamine N-acetyltransferases: Structural and functional implications of polymorphisms. Toxicology. 254(3). 170–183. 91 indexed citations
20.
Lack, Nathan A., David C. Dale, Gary Calandra, et al.. (2005). A pharmacokinetic-pharmacodynamic model for the mobilization of CD34 hematopoietic progenitor cells by AMD3100. Clinical Pharmacology & Therapeutics. 77(5). 427–436. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taoufik Ouatas Breakdown of academic impact, for papers by Joan Cao Breakdown of academic impact, for papers by Alexandre Evrard Breakdown of academic impact, for papers by Renae M. Crosby Breakdown of academic impact, for papers by Victoria J. Findlay Breakdown of academic impact, for papers by Amit Kulkarni Breakdown of academic impact, for papers by Sih‐Han Liao Breakdown of academic impact, for papers by Makoto Asada Breakdown of academic impact, for papers by Naoyuki Kanzaki Breakdown of academic impact, for papers by Daniel A. Harki
Rankless by CCL
2026